Pyrimidine and quinoline potentiators of metabotropic glutamate receptors

Details for Australian Patent Application No. 2005302608 (hide)

Owner Merck & Co., Inc.

Inventors Cosford, Nicholas; Chua, Peter Cheng; Hu, Essa H.; Hutchinson, John H.; Vernier, Jean-Michel

Agent Spruson & Ferguson

Pub. Number AU-A-2005302608

PCT Pub. Number WO2006/049968

Priority 60/622,868 28.10.04 US

Filing date 24 October 2005

Wipo publication date 11 May 2006

International Classifications

C07D 239/26 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/47 (2006.01) - Quinolines

A61K 31/505 (2006.01) - Pyrimidines

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/049968 Priority application(s): WO2006/049968

5 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302611-Package for sale, storage and application of two-part coatings

2005302607-Improved furnace cooling system and method